Azevan Pharmaceuticals
PrivateLast Round
Grant
Mar 1, 2026
Total Funding Raised
$11.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Azevan Pharmaceuticals is a biotechnology company that develops novel small-molecule therapeutics to treat stress-related central nervous system disorders and neurodegenerative conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Azevan Pharmaceuticals Comparables
Compare Azevan Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuphoria Therapeutics Inc. | 77% | |
| MapLight Therapeutics | 73% | |
| Nobilis Therapeutics | 73% | |
Azevan Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2026 | ||||
| Series C | Oct 1, 2013 |
Azevan Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| Scientific Health Development | Series C |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| Ascent Biomedical Ventures | Series C |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Received grant from the United States Department of Defense.
- Jan 31, 2026
Monthly visitors grew 92% MoM.
Azevan Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Azevan Pharmaceuticals's valuation, stock price, and market status.